Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
2 |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 7.5 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
2 |
Adrenaline 1 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline 1 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline 2.5 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline 2.5 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline 10 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline 10 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline (as adrenaline acid tartrate) 1 mg/mL and guanethidine 5 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline (as adrenaline acid tartrate) 5 mg/mL and guanethidine 10 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epinephrine 10 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epinephrine 10 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epinephrine 2 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epinephrine 2 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline 10 microgram/mL and mepivacaine hydrochloride 20 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline 10 microgram/mL and mepivacaine hydrochloride 20 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline 1 mg/mL nasal solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline 1 mg/mL nasal solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and prilocaine hydrochloride 40 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
2 |
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cocaine (as cocaine hydrochloride) 50 milligram/1 milliliter and epinephrine 200 microgram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely cocaine (as cocaine hydrochloride) 50 milligram/1 milliliter and epinephrine 200 microgram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
2 |
Adrenaline and bupivacaine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
2 |
Adrenaline and lidocaine only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Product containing only cocaine and epinephrine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
2 |
Product containing only articaine and epinephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Product containing articaine and epinephrine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Product containing only articaine and epinephrine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline- and prilocaine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
2 |
Adrenaline and mepivacaine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline- and prilocaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
2 |
Adrenaline- and bupivacaine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
2 |
Adrenaline 1 microgram/mg and lidocaine hydrochloride 100 microgram/mg cutaneous patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline 1 microgram/mg and lidocaine hydrochloride 100 microgram/mg cutaneous patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline and prilocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
2 |
Adrenaline and prilocaine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
2 |
Product containing epinephrine and mepivacaine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline- and cocaine-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
2 |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
2 |
Adrenaline- and lidocaine-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 15 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline- and etidocaine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epinephrine 12.5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epinephrine 12.5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Product containing articaine and epinephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline and etidocaine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline 500 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline 500 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Product containing epinephrine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Epinephrine 5 mg/mL and guanethidine monosulfate 30 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
2 |
Epinephrine 5 mg/mL and guanethidine monosulfate 30 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
2 |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epinephrine (as epinephrine bitartrate) 12.5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Administration of epinephrine (procedure) |
Direct substance |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Infusion of epinephrine (procedure) |
Direct substance |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline 1.667 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline 1.667 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Injection of epinephrine into lesion of duodenum for hemostasis |
Direct substance |
False |
Epinephrine (substance) |
Inferred relationship |
Some |
3 |
Adrenaline 100 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Adrenaline 100 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Endoscopic injection of epinephrine into lesion of stomach for control of hemorrhage |
Direct substance |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Endoscopic injection of epinephrine into lesion of duodenum for control of hemorrhage |
Direct substance |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
24 hour urine adrenaline output measurement |
Component |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
24 hour urine free adrenaline output measurement |
Component |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Plasma adrenaline measurement |
Component |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Serum adrenaline measurement |
Component |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |
Urine epinephrine measurement |
Component |
True |
Epinephrine (substance) |
Inferred relationship |
Some |
1 |